Company news
Pharma Equity Group A/s Class A (OMXCOP:PEG) news
Pharma Equity Group A/s Class A news releases on 6ix. Latest, Sep 7, 2026: Pharma Equity Group A/S – Challenge to Arbitral Award
Press releases & updates
Pharma Equity Group A/S – Challenge to Arbitral Award
September 7, 2026
Pharma Equity Group’s subsidiary Reponex takes key step forward in Inflammatory Bowel Disease with upcoming European patent grant
May 11, 2026
Proceedings of the Annual General Meeting of Pharma Equity Group A/S
April 17, 2026
Notice convening the annual general meeting in Pharma Equity Group A/S
March 25, 2026
Pharma Equity Group A/S - Annual Report 2025
March 25, 2026
UPDATE OF THE FINANCIAL CALENDAR FOR 2026
March 18, 2026
SUPPLEMENTARY INFORMATION (CORRECTIVE INFORMATION) TO THE ANNUAL REPORT 2024 AND THE INTERIM REPORT FOR H1 2025
February 26, 2026
2026 Financial Calendar
February 3, 2026
Pharma Equity Group – Strategic update and adjustment of expectations
December 29, 2025
Pharma Equity Group executes on the Company's new strategy: Enters into Letter of Intent to acquire the MedTech company Otiom A/S
December 10, 2025
Pharma Equity Group A/S’ agreement with Danske Bank as liquidity provider will terminate on 1 January 2026
December 3, 2025
The Board of Directors' resolution on the issuance of convertible loans
December 1, 2025
Corrective information regarding the Annual Report 2024 and the Interim Report for H1 2025 following an order from the Danish Business Authority
November 26, 2025
Correction: Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis
September 2, 2025
Pharma Equity Group's subsidiary, Reponex Pharmaceuticals A/S, receives regulatory approval to initiate pivotal clinical trial with RNX-011 for life-threatening peritonitis
September 1, 2025
Consolidated Interim Report 1 January – 30 June 2025
August 14, 2025
Pharma Equity Group A/S Launches New Strategy to Drive Growth and Shareholder Returns
May 28, 2025
Passing of the General Meeting of Pharma Equity Group A/S
May 5, 2025